Oropharynx Cancer clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
open to eligible people ages 18 years and up
This is a single-arm, observational registry study determining the effects of reduced radiation dose in select patients with human papillomavirus (HPV) positive oropharyngeal cancer.
Orange, California
Last updated: